PATENT CLAIM ANALYSIS

Application Number: 16155100
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["424", "443000"]

Abstract:
The present invention relates to products and methods for treatment of various symptoms in a patient, including treatment of pain suffered by a patient. The invention more particularly relates to self-supporting dosage forms which provide an active agent while providing sufficient buccal adhesion of the dosage form. Further, the present invention provides a dosage form which is useful in reducing the likelihood of diversion abuse of the active agent.

Claim (Index 9):
The composition of  claim 1 , wherein said antagonist is naloxone or a pharmaceutically acceptable salt thereof and said agonist is buprenorphine or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 97.0
- Lexical Diversity: 1.57447
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14196082', '12537571', '14989669', '15069875', '14390322']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7427733969287169
- 35 USC 102 Novelty (BERT): 0.5574402930905037
- Combined Prediction Score: 0.7242400865448957
- Mean Citation Score: 354.520434
- Max Citation Score: 413.72986
- Similarity Product: 349.259311703403

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test